Tazemetostat Hydrobromide Clinical Trials

1 actively recruiting trial across 1 location

Also known as: EPZ-6438 Monohydrobromide, TAZVERIK, Tazemetostat Monohydrobromide

Filter by location:

Los Angeles, California1 trial

Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

Keck Medicine of USC Koreatown

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.